Dichloromethylene-bisphosphonate
WebDiphosphonate, Dichloromethylene Chemistry Full Screen View Also known as: 22560-50-5, Clodronic acid disodium salt, Disodium clodronate, Clasteon, Loron, Lodronate Molecular Formula CH 2 Cl 2 Na 2 O 6 P 2 Molecular Weight 288.85 g/mol InChI Key HJKBJIYDJLVSAO-UHFFFAOYSA-L FDA UNII Y05R4GCQ1H A diphosphonate which … WebClodronate (dichloromethylene bisphosphonate) inhibits the activity of osteoclasts, thereby preventing bone resorption in disorders characterized by excessive bone loss. Intravenously injected clodronate encapsulated in liposomes is also known to inactivate phagocytic cells in spleen and liver in vivo. The macrophage suppressive effect of ...
Dichloromethylene-bisphosphonate
Did you know?
WebDisplacement of platelets from blood to spleen following intravenous injection of liposomes encapsulating dichloromethylene bisphosphonate Displacement of platelets from blood to spleen following intravenous injection of liposomes encapsulating dichloromethylene bisphosphonate Authors M Shibazaki 1 , M Nakamura , Y Nitta , Y Endo Affiliation WebClodronate (dichloromethylene bisphosphonate) accumualtes extensively in the bone by binding to apatite crystals. We found recently that the drug also accumulates in the spleen and, to a lesser extent, in the liver of mice and rats. In the present study, the role of macrophages in soft tissue accumulation was studied in mice by autoradiography ...
WebClodronate (dichloromethylene bisphosphonate) accumulates extensively in bone by binding to hydroxyapatite crystals. In an hypo-osmotic vehicle, it accumulates also in the … WebDichlorophenylphosphine is an organophosphorus compound with the formula C 6 H 5 PCl 2. This colourless viscous liquid is commonly used in the synthesis of organophosphines …
WebSigma-Aldrich. 233183. Clodronate, Disodium Salt - CAS 88416-50-6 - Calbiochem. A non-amino, chloro-containing bisphosphonate that acts as a potent inhibitor of osteoclast … WebOct 1, 1994 · A PROSPECTIVE, CONTROLLED, NONRANDOMIZED STUDY ON PROPHYLACTIC PARENTERAL DICHLOROMETHYLENE BISPHOSPHONATE (CLODRONATE) IN MULTIPLE-MYELOMA International Journal of Oncology Journal Home Current Issue Forthcoming Issue
WebAfter pretreating mice with intranasal instillation of liposomal dichloromethylene-bisphosphonate to selectively deplete alveolar macrophages, the authors demonstrated that macrophage-depleted mice had a higher mortality from experimental pneumococcal pneumonia than did control mice pretreated with either intranasal saline or liposomes.
Webwww.ncbi.nlm.nih.gov ipledge medication listWebOBJECTIVE The reflex sympathetic dystrophy syndrome (RSDS) is a painful limb disorder, for which a consistently effective treatment has not yet been identified. The disease is associated with increased bone resorption and patchy osteoporosis, which might benefit from treatment with bisphosphonates, powerful inhibitors of bone resorption. … ipledge medicationsWebPurpose. Non-nitrogen-containing bisphosphonates, such as clodronate (dichloromethylene bisphosphonate), appear to act as prodrugs, their active form being the AppCp-type analogues of ATP. To further elucidate this, we examined the cellular uptake of clodronate and intracellular accumulation of the metabolite of clodronate … ipledge missed windowWebClodronate, Disodium, Tetrahydrate, Dichloromethylene-bisphosphonate, Disodium Tetrahydrate: Description: A non-amino, chloro-containing, bisphosphonate that acts as … ipledge newsWebthe bacteria with the bisphosphonate DMDP (dichloromethylene diphosphonic acid) causes a stronger synergistic effect together with copper than polyP with copper. Bisphosphonates are pyrophosphate analogs, comprising a carbon atom (P-C-P) instead of an oxygen atom (P-O-P) between the two phosphorus atoms (reviewed in [38]). ipledge new patientWebJul 3, 2024 · Bisphosphonates are a group of drugs that intervene in the bone resorption process, producing cellular death of osteoclasts. These drugs are used for skeletal conditions, such as osteoporosis in humans, and are available for veterinary medical use. ipledge monthly questionsWebData on the long‐term treatment of myeloma bone disease with bisphosphonates are scanty. In a prospective pilot trial we evaluated the effect of long‐term parenteral … ipledge number login